Deborah Paula Waber, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 18 | 2015 | 1560 | 2.000 |
Why?
|
| Dyslexia | 9 | 2020 | 215 | 1.900 |
Why?
|
| Neuropsychological Tests | 33 | 2021 | 7148 | 1.550 |
Why?
|
| Cognition Disorders | 19 | 2016 | 3985 | 1.420 |
Why?
|
| Infant Nutrition Disorders | 4 | 2014 | 70 | 1.350 |
Why?
|
| Protein-Energy Malnutrition | 9 | 2016 | 189 | 1.290 |
Why?
|
| Reading | 9 | 2018 | 543 | 1.070 |
Why?
|
| Achievement | 6 | 2016 | 288 | 1.000 |
Why?
|
| Cognition | 19 | 2020 | 7080 | 0.920 |
Why?
|
| Cranial Irradiation | 10 | 2010 | 395 | 0.920 |
Why?
|
| Child Development | 12 | 2022 | 2337 | 0.830 |
Why?
|
| Convergence, Ocular | 2 | 2019 | 26 | 0.790 |
Why?
|
| Education, Special | 3 | 2021 | 86 | 0.770 |
Why?
|
| Vision Disorders | 2 | 2019 | 1093 | 0.740 |
Why?
|
| Ocular Motility Disorders | 2 | 2019 | 144 | 0.710 |
Why?
|
| Apraxias | 1 | 2020 | 58 | 0.700 |
Why?
|
| Prednisone | 4 | 2013 | 1567 | 0.700 |
Why?
|
| Intelligence Tests | 13 | 2016 | 505 | 0.690 |
Why?
|
| Mental Processes | 4 | 2007 | 247 | 0.650 |
Why?
|
| Adolescent Development | 2 | 2014 | 282 | 0.650 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 11 | 2020 | 3743 | 0.640 |
Why?
|
| Child | 86 | 2023 | 80969 | 0.620 |
Why?
|
| Barbados | 10 | 2016 | 52 | 0.600 |
Why?
|
| Intelligence | 11 | 2013 | 927 | 0.530 |
Why?
|
| Behavior | 2 | 2011 | 543 | 0.530 |
Why?
|
| Adult Children | 1 | 2016 | 104 | 0.520 |
Why?
|
| Survivors | 4 | 2015 | 2383 | 0.510 |
Why?
|
| Reaction Time | 10 | 2004 | 2102 | 0.510 |
Why?
|
| Memory Disorders | 7 | 2012 | 1203 | 0.490 |
Why?
|
| Psychomotor Performance | 5 | 2014 | 1895 | 0.490 |
Why?
|
| Family Health | 2 | 2016 | 1255 | 0.450 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2016 | 352 | 0.450 |
Why?
|
| Concept Formation | 2 | 2014 | 161 | 0.430 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2012 | 1893 | 0.410 |
Why?
|
| Dexamethasone | 3 | 2013 | 1965 | 0.410 |
Why?
|
| Psychometrics | 6 | 2018 | 3066 | 0.400 |
Why?
|
| Child Behavior Disorders | 3 | 2011 | 813 | 0.380 |
Why?
|
| Central Nervous System Diseases | 3 | 2007 | 521 | 0.380 |
Why?
|
| Adolescent | 50 | 2023 | 89247 | 0.360 |
Why?
|
| Epilepsy, Rolandic | 1 | 2011 | 57 | 0.360 |
Why?
|
| Germinoma | 1 | 2011 | 132 | 0.350 |
Why?
|
| Parents | 6 | 2022 | 3597 | 0.350 |
Why?
|
| Malnutrition | 1 | 2016 | 631 | 0.340 |
Why?
|
| Accidents | 1 | 2010 | 164 | 0.330 |
Why?
|
| Schools | 4 | 2021 | 1498 | 0.330 |
Why?
|
| Family Relations | 2 | 2012 | 318 | 0.330 |
Why?
|
| Evoked Potentials, Auditory | 3 | 2001 | 533 | 0.310 |
Why?
|
| Quality of Life | 3 | 2021 | 13510 | 0.310 |
Why?
|
| Male | 84 | 2022 | 365249 | 0.310 |
Why?
|
| Nutritional Status | 1 | 2016 | 1627 | 0.300 |
Why?
|
| Craniopharyngioma | 3 | 2006 | 279 | 0.290 |
Why?
|
| Female | 86 | 2022 | 397464 | 0.290 |
Why?
|
| Memory, Short-Term | 1 | 2014 | 1010 | 0.290 |
Why?
|
| Infant | 21 | 2022 | 36541 | 0.280 |
Why?
|
| Brain | 14 | 2018 | 27476 | 0.280 |
Why?
|
| Child Behavior | 1 | 2012 | 865 | 0.270 |
Why?
|
| Visual Perception | 7 | 2003 | 1407 | 0.270 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 800 | 0.270 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 7 | 2011 | 11886 | 0.270 |
Why?
|
| Motor Skills | 5 | 2003 | 523 | 0.270 |
Why?
|
| Radiotherapy | 3 | 2011 | 1506 | 0.260 |
Why?
|
| Emotions | 2 | 2020 | 2768 | 0.250 |
Why?
|
| Developmental Disabilities | 2 | 2008 | 1521 | 0.250 |
Why?
|
| Methotrexate | 8 | 2007 | 1723 | 0.250 |
Why?
|
| Humans | 104 | 2023 | 768887 | 0.240 |
Why?
|
| Anomia | 1 | 2004 | 13 | 0.240 |
Why?
|
| Radiation Injuries | 4 | 2010 | 1203 | 0.240 |
Why?
|
| Mood Disorders | 1 | 2011 | 1129 | 0.240 |
Why?
|
| Child, Preschool | 24 | 2015 | 42684 | 0.230 |
Why?
|
| Verbal Behavior | 4 | 2019 | 336 | 0.230 |
Why?
|
| Referral and Consultation | 3 | 2003 | 3626 | 0.230 |
Why?
|
| Attention | 10 | 2008 | 2425 | 0.230 |
Why?
|
| Folic Acid | 1 | 2011 | 1336 | 0.230 |
Why?
|
| Problem Solving | 2 | 2006 | 443 | 0.230 |
Why?
|
| Oxidative Stress | 1 | 2015 | 3138 | 0.220 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2012 | 6031 | 0.220 |
Why?
|
| Aptitude | 1 | 2003 | 43 | 0.210 |
Why?
|
| Regression Analysis | 6 | 2012 | 6346 | 0.210 |
Why?
|
| Follow-Up Studies | 15 | 2021 | 39394 | 0.200 |
Why?
|
| Brain Neoplasms | 4 | 2011 | 9213 | 0.200 |
Why?
|
| Auditory Perception | 4 | 2002 | 588 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2020 | 36861 | 0.200 |
Why?
|
| Pituitary Neoplasms | 3 | 2006 | 1326 | 0.190 |
Why?
|
| Injections, Spinal | 5 | 2007 | 318 | 0.180 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 4251 | 0.180 |
Why?
|
| Language Tests | 2 | 2000 | 193 | 0.180 |
Why?
|
| Temperament | 1 | 2022 | 301 | 0.170 |
Why?
|
| Fingers | 1 | 2003 | 512 | 0.170 |
Why?
|
| Speech Disorders | 1 | 2000 | 180 | 0.160 |
Why?
|
| Antineoplastic Agents | 3 | 2013 | 13699 | 0.160 |
Why?
|
| Factor Analysis, Statistical | 2 | 2018 | 1002 | 0.160 |
Why?
|
| Psychomotor Disorders | 1 | 2000 | 149 | 0.160 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2007 | 930 | 0.160 |
Why?
|
| Community Health Planning | 2 | 2012 | 164 | 0.160 |
Why?
|
| Functional Laterality | 6 | 2014 | 2269 | 0.160 |
Why?
|
| Otitis Media with Effusion | 1 | 2000 | 115 | 0.160 |
Why?
|
| Accommodation, Ocular | 1 | 2018 | 47 | 0.150 |
Why?
|
| Vision Tests | 1 | 2018 | 160 | 0.150 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 2445 | 0.150 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 2517 | 0.150 |
Why?
|
| Urban Population | 1 | 2006 | 2045 | 0.140 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2019 | 227 | 0.140 |
Why?
|
| Conduct Disorder | 3 | 2012 | 245 | 0.140 |
Why?
|
| Transposition of Great Vessels | 1 | 2021 | 580 | 0.130 |
Why?
|
| Longitudinal Studies | 10 | 2013 | 14795 | 0.130 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 2433 | 0.130 |
Why?
|
| Self Report | 3 | 2020 | 3773 | 0.130 |
Why?
|
| Educational Status | 3 | 2016 | 2515 | 0.130 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2012 | 794 | 0.130 |
Why?
|
| Socioeconomic Factors | 6 | 2013 | 7860 | 0.130 |
Why?
|
| Movement | 1 | 2003 | 1490 | 0.130 |
Why?
|
| Cytarabine | 3 | 2007 | 697 | 0.130 |
Why?
|
| Epilepsy | 3 | 2023 | 3326 | 0.130 |
Why?
|
| Age Factors | 9 | 2012 | 18454 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 16051 | 0.120 |
Why?
|
| Depressive Disorder | 2 | 2023 | 3726 | 0.120 |
Why?
|
| Cerebellum | 1 | 2003 | 1522 | 0.120 |
Why?
|
| Motor Cortex | 1 | 2003 | 1014 | 0.120 |
Why?
|
| Combined Modality Therapy | 9 | 2010 | 8559 | 0.120 |
Why?
|
| Nervous System Diseases | 2 | 2003 | 1665 | 0.120 |
Why?
|
| Sex Factors | 10 | 2012 | 10641 | 0.120 |
Why?
|
| Analysis of Variance | 5 | 2012 | 6242 | 0.120 |
Why?
|
| Cerebral Cortex | 3 | 2019 | 5834 | 0.120 |
Why?
|
| Task Performance and Analysis | 3 | 2011 | 771 | 0.110 |
Why?
|
| Electroencephalography | 3 | 2011 | 6318 | 0.100 |
Why?
|
| Personality Inventory | 2 | 2013 | 1018 | 0.100 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2010 | 4642 | 0.100 |
Why?
|
| Adaptation, Psychological | 1 | 2003 | 2667 | 0.100 |
Why?
|
| Suicide | 1 | 2023 | 1606 | 0.100 |
Why?
|
| Personal Satisfaction | 1 | 2016 | 645 | 0.100 |
Why?
|
| Depression | 2 | 2011 | 8240 | 0.100 |
Why?
|
| Cross-Sectional Studies | 6 | 2012 | 26384 | 0.100 |
Why?
|
| Mental Recall | 2 | 2010 | 1226 | 0.100 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2000 | 1535 | 0.100 |
Why?
|
| Estradiol | 1 | 2019 | 1952 | 0.100 |
Why?
|
| Amygdala | 1 | 2019 | 1382 | 0.090 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2020 | 2426 | 0.090 |
Why?
|
| Behavior, Animal | 3 | 2016 | 1879 | 0.090 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2014 | 390 | 0.090 |
Why?
|
| Severity of Illness Index | 5 | 2016 | 15955 | 0.090 |
Why?
|
| Mathematics | 2 | 2021 | 704 | 0.080 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2011 | 294 | 0.080 |
Why?
|
| Personality | 1 | 2013 | 560 | 0.080 |
Why?
|
| Neuropsychology | 1 | 2010 | 110 | 0.080 |
Why?
|
| Organ Size | 1 | 2014 | 2268 | 0.080 |
Why?
|
| Executive Function | 2 | 2022 | 1405 | 0.080 |
Why?
|
| Social Adjustment | 1 | 2011 | 636 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 2862 | 0.080 |
Why?
|
| Verbal Learning | 1 | 2010 | 465 | 0.080 |
Why?
|
| Case-Control Studies | 5 | 2012 | 22294 | 0.080 |
Why?
|
| Memory | 3 | 2008 | 2210 | 0.070 |
Why?
|
| Adult | 15 | 2016 | 223818 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2016 | 41800 | 0.070 |
Why?
|
| Aging | 2 | 2019 | 8765 | 0.070 |
Why?
|
| Brain Waves | 1 | 2011 | 418 | 0.070 |
Why?
|
| Statistics as Topic | 2 | 2011 | 2359 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 20244 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2022 | 4542 | 0.070 |
Why?
|
| Ependymoma | 2 | 2003 | 328 | 0.070 |
Why?
|
| Dominance, Cerebral | 2 | 1985 | 624 | 0.070 |
Why?
|
| Interviews as Topic | 2 | 2011 | 2742 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2019 | 54950 | 0.070 |
Why?
|
| Corpus Callosum | 1 | 2011 | 754 | 0.070 |
Why?
|
| Space Perception | 4 | 1982 | 467 | 0.070 |
Why?
|
| Motor Activity | 4 | 2008 | 2722 | 0.070 |
Why?
|
| Educational Measurement | 2 | 2006 | 1260 | 0.060 |
Why?
|
| Infant, Premature | 1 | 1995 | 2121 | 0.060 |
Why?
|
| Methylphenidate | 1 | 2010 | 491 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 6085 | 0.060 |
Why?
|
| Maternal Behavior | 2 | 2022 | 309 | 0.060 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 2257 | 0.060 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 1989 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2018 | 9081 | 0.060 |
Why?
|
| Wakefulness | 1 | 2011 | 1284 | 0.060 |
Why?
|
| Developing Countries | 1 | 2016 | 2906 | 0.060 |
Why?
|
| Child Nutrition Disorders | 1 | 2005 | 140 | 0.060 |
Why?
|
| Alleles | 1 | 2015 | 6901 | 0.060 |
Why?
|
| Cocaine | 1 | 2008 | 960 | 0.050 |
Why?
|
| Adolescent Behavior | 1 | 2012 | 1190 | 0.050 |
Why?
|
| Brain Mapping | 5 | 2011 | 6740 | 0.050 |
Why?
|
| Self-Assessment | 1 | 2006 | 400 | 0.050 |
Why?
|
| Optic Nerve Glioma | 1 | 2003 | 32 | 0.050 |
Why?
|
| Young Adult | 6 | 2019 | 60110 | 0.050 |
Why?
|
| Comorbidity | 4 | 2007 | 10591 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 3836 | 0.050 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 1997 | 647 | 0.050 |
Why?
|
| Disease-Free Survival | 2 | 2004 | 6856 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2012 | 3585 | 0.050 |
Why?
|
| Speech Perception | 2 | 1985 | 512 | 0.050 |
Why?
|
| Data Collection | 1 | 2011 | 3322 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2016 | 4432 | 0.050 |
Why?
|
| Risk Factors | 6 | 2023 | 74971 | 0.050 |
Why?
|
| Postoperative Complications | 4 | 2014 | 15889 | 0.050 |
Why?
|
| Central Nervous System Stimulants | 1 | 2010 | 1182 | 0.050 |
Why?
|
| Time Factors | 4 | 2011 | 40266 | 0.050 |
Why?
|
| Risk | 2 | 2011 | 9621 | 0.050 |
Why?
|
| Evoked Potentials, Visual | 1 | 2003 | 420 | 0.040 |
Why?
|
| Genotype | 1 | 2015 | 13048 | 0.040 |
Why?
|
| Nutrition Disorders | 1 | 1981 | 204 | 0.040 |
Why?
|
| Phonetics | 1 | 2001 | 204 | 0.040 |
Why?
|
| Sexual Maturation | 1 | 1981 | 261 | 0.040 |
Why?
|
| Food, Fortified | 1 | 1981 | 189 | 0.040 |
Why?
|
| Hippocampus | 1 | 2012 | 3786 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2007 | 1842 | 0.040 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1981 | 360 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2023 | 81892 | 0.040 |
Why?
|
| Neoplasms | 1 | 2008 | 22390 | 0.040 |
Why?
|
| Asparaginase | 1 | 2000 | 240 | 0.040 |
Why?
|
| Astrocytoma | 1 | 2003 | 780 | 0.040 |
Why?
|
| Random Allocation | 1 | 2003 | 2396 | 0.040 |
Why?
|
| Acoustic Stimulation | 2 | 2001 | 1256 | 0.040 |
Why?
|
| Leucovorin | 1 | 2000 | 643 | 0.040 |
Why?
|
| Field Dependence-Independence | 1 | 1977 | 23 | 0.040 |
Why?
|
| Sex Characteristics | 3 | 2019 | 2660 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2007 | 2167 | 0.040 |
Why?
|
| Turner Syndrome | 1 | 1979 | 130 | 0.040 |
Why?
|
| Boston | 1 | 2010 | 9375 | 0.040 |
Why?
|
| Vincristine | 1 | 2000 | 1040 | 0.040 |
Why?
|
| Mothers | 2 | 2022 | 2211 | 0.030 |
Why?
|
| Social Environment | 1 | 1981 | 1016 | 0.030 |
Why?
|
| Sex | 1 | 1976 | 53 | 0.030 |
Why?
|
| Amitriptyline | 1 | 1976 | 112 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2008 | 2541 | 0.030 |
Why?
|
| Individuality | 1 | 1977 | 307 | 0.030 |
Why?
|
| Arteries | 1 | 2021 | 1126 | 0.030 |
Why?
|
| Puberty | 1 | 2019 | 501 | 0.030 |
Why?
|
| Prednisolone | 2 | 1994 | 327 | 0.030 |
Why?
|
| Sleep | 1 | 2011 | 4820 | 0.030 |
Why?
|
| Neurologic Examination | 2 | 1996 | 916 | 0.030 |
Why?
|
| Mental Disorders | 2 | 2007 | 6879 | 0.030 |
Why?
|
| Growth | 1 | 1997 | 366 | 0.030 |
Why?
|
| Parent-Child Relations | 1 | 1999 | 773 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2000 | 14751 | 0.030 |
Why?
|
| Remission Induction | 1 | 2000 | 2411 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2012 | 13054 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2001 | 1345 | 0.030 |
Why?
|
| Aggression | 2 | 2011 | 750 | 0.030 |
Why?
|
| Psychological Tests | 3 | 2008 | 642 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2020 | 1070 | 0.030 |
Why?
|
| Observer Variation | 1 | 2000 | 2623 | 0.030 |
Why?
|
| Leukemia, Experimental | 1 | 1994 | 225 | 0.030 |
Why?
|
| Body Weight | 4 | 2005 | 4628 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2003 | 2122 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2000 | 2234 | 0.030 |
Why?
|
| Prenatal Care | 1 | 1981 | 1159 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 1995 | 1379 | 0.030 |
Why?
|
| Suicidal Ideation | 1 | 2023 | 1462 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 1990 | 4429 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2000 | 15471 | 0.030 |
Why?
|
| ROC Curve | 1 | 2000 | 3629 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2001 | 1970 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2000 | 1410 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2003 | 2110 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2012 | 258 | 0.020 |
Why?
|
| Pediatrics | 1 | 2007 | 3628 | 0.020 |
Why?
|
| Family | 1 | 2022 | 3208 | 0.020 |
Why?
|
| Income | 1 | 2000 | 1878 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2004 | 10115 | 0.020 |
Why?
|
| Prevalence | 2 | 2023 | 15875 | 0.020 |
Why?
|
| Body Height | 2 | 2005 | 1568 | 0.020 |
Why?
|
| United States | 2 | 2012 | 73180 | 0.020 |
Why?
|
| Dental Caries | 1 | 1995 | 429 | 0.020 |
Why?
|
| Neurofibromatosis 1 | 1 | 1996 | 561 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 1995 | 868 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 1981 | 2339 | 0.020 |
Why?
|
| Psycholinguistics | 1 | 2010 | 81 | 0.020 |
Why?
|
| Nervous System | 1 | 1994 | 547 | 0.020 |
Why?
|
| Seizures | 1 | 2023 | 3000 | 0.020 |
Why?
|
| Orientation | 2 | 1984 | 320 | 0.020 |
Why?
|
| Cerebellar Neoplasms | 1 | 1995 | 591 | 0.020 |
Why?
|
| Pattern Recognition, Visual | 2 | 1986 | 826 | 0.020 |
Why?
|
| Medulloblastoma | 1 | 1995 | 683 | 0.020 |
Why?
|
| Oral Health | 1 | 1995 | 493 | 0.020 |
Why?
|
| Color Perception Tests | 1 | 2008 | 12 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2020 | 3120 | 0.020 |
Why?
|
| Recurrence | 1 | 2001 | 8512 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2013 | 643 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2016 | 1738 | 0.020 |
Why?
|
| Infant, Newborn | 4 | 2012 | 26394 | 0.020 |
Why?
|
| Color Perception | 1 | 2008 | 213 | 0.020 |
Why?
|
| Anorexia Nervosa | 1 | 1976 | 1364 | 0.020 |
Why?
|
| Pregnancy | 3 | 2022 | 30175 | 0.020 |
Why?
|
| Anxiety | 1 | 2022 | 4677 | 0.020 |
Why?
|
| Survival Rate | 1 | 2001 | 12873 | 0.020 |
Why?
|
| Child of Impaired Parents | 1 | 2010 | 463 | 0.020 |
Why?
|
| Environment | 1 | 2012 | 1125 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2002 | 65485 | 0.020 |
Why?
|
| Parietal Lobe | 2 | 2001 | 866 | 0.010 |
Why?
|
| Middle Aged | 3 | 2016 | 223740 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2931 | 0.010 |
Why?
|
| Rats | 3 | 2016 | 23847 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1999 | 13020 | 0.010 |
Why?
|
| Mass Screening | 1 | 2000 | 5455 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 2108 | 0.010 |
Why?
|
| Social Class | 2 | 1982 | 2009 | 0.010 |
Why?
|
| Perception | 1 | 2008 | 1209 | 0.010 |
Why?
|
| Juvenile Delinquency | 1 | 1982 | 116 | 0.010 |
Why?
|
| Postpartum Period | 1 | 2008 | 1198 | 0.010 |
Why?
|
| Linear Models | 1 | 2010 | 5890 | 0.010 |
Why?
|
| Cues | 1 | 1985 | 884 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2010 | 1924 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 18366 | 0.010 |
Why?
|
| Oxygen | 1 | 2010 | 4273 | 0.010 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1981 | 585 | 0.010 |
Why?
|
| Reference Values | 1 | 1985 | 4941 | 0.010 |
Why?
|
| Endocrine Glands | 1 | 1977 | 101 | 0.010 |
Why?
|
| Spatial Behavior | 1 | 1976 | 89 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2010 | 12469 | 0.010 |
Why?
|
| Leukemic Infiltration | 1 | 1995 | 47 | 0.010 |
Why?
|
| Child Health Services | 1 | 1981 | 645 | 0.010 |
Why?
|
| Cranial Fossa, Posterior | 1 | 1995 | 134 | 0.010 |
Why?
|
| Gingivitis | 1 | 1995 | 125 | 0.010 |
Why?
|
| Brain Damage, Chronic | 1 | 1995 | 267 | 0.010 |
Why?
|
| Dental Plaque | 1 | 1995 | 214 | 0.010 |
Why?
|
| Radiation Injuries, Experimental | 1 | 1994 | 88 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1995 | 877 | 0.010 |
Why?
|
| Speech | 1 | 1996 | 558 | 0.010 |
Why?
|
| Craniotomy | 1 | 1995 | 747 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1995 | 1793 | 0.010 |
Why?
|
| Social Behavior | 1 | 1996 | 1146 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 2087 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1994 | 1421 | 0.010 |
Why?
|
| Animals | 3 | 2016 | 169408 | 0.000 |
Why?
|
| Language | 1 | 1996 | 1559 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1994 | 8200 | 0.000 |
Why?
|